BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 16051585)

  • 21. [Pulmonary aspergillosis and HIV infection: about two cases].
    El Fane M; Ouladlahsen A; Bakhatar A; Sodqi M; El Filali KM; Bahlaoui A; Chakib A
    Rev Pneumol Clin; 2012 Feb; 68(1):36-9. PubMed ID: 22056792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
    Gasch O; Fernández N; Ayats J; Santin M
    Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):193-4. PubMed ID: 19306722
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B?
    Pagano L; Valentini CG; Fianchi L; Caira M
    J Chemother; 2011 Feb; 23(1):5-8. PubMed ID: 21482486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive aspergillosis with central nervous system dissemination in a presumably immunocompetent, non-neutropenic patient: case report and review.
    Garcia RJ; Troya P; Edwards C
    South Med J; 2006 Jun; 99(6):607-10. PubMed ID: 16800416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of brain aspergillosis with voriconazole.
    Tattevin P; Bruneel F; Lellouche F; de Broucker T; Chevret S; Wolff M; Régnier B
    Clin Microbiol Infect; 2004 Oct; 10(10):928-31. PubMed ID: 15373890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
    Izumikawa K; Ohtsu Y; Kawabata M; Takaya H; Miyamoto A; Sakamoto S; Kishi K; Tsuboi E; Homma S; Yoshimura K
    Med Mycol; 2007 May; 45(3):273-8. PubMed ID: 17464848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Voriconazole versus amphotericin B for invasive aspergillosis.
    Blot F; Edé C; Nitenberg GM
    N Engl J Med; 2002 Dec; 347(25):2080-1; author reply 2080-1. PubMed ID: 12490695
    [No Abstract]   [Full Text] [Related]  

  • 28. Lack of efficacy of voriconazole therapy in 2 patients with pulmonary fungus balls.
    Gutierrez F; Masia M; Ramos JM; Elia M; Rodriguez-Tudela JL; Cuenca-Estrella M
    Clin Infect Dis; 2005 Jun; 40(11):1706-7. PubMed ID: 15889381
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination antifungal therapy for invasive aspergillosis.
    Cesaro S; Visintin G
    Clin Infect Dis; 2005 Apr; 40(7):1073-5; author reply 1075-6. PubMed ID: 15825015
    [No Abstract]   [Full Text] [Related]  

  • 30. [A case of pulmonary alternariosis complicated with aspergillosis].
    Tan Y; Song M; Peng H; Guo W; Zhou Q; Long Y; Luo M; Chen P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 42(9):1122-1128. PubMed ID: 28989162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary aspergillosis in an immunocompetent patient.
    Ko JP; Kim DH; Shepard JA
    J Thorac Imaging; 2002 Jan; 17(1):70-3. PubMed ID: 11828215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease.
    Verma A; Williams S; Trifilio S; Zembower T; Mehta J
    Bone Marrow Transplant; 2004 May; 33(10):1065-6. PubMed ID: 15048146
    [No Abstract]   [Full Text] [Related]  

  • 33. Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia.
    Shouldice E; Fernandez C; McCully B; Schmidt M; Fraser R; Cook C
    J Pediatr Hematol Oncol; 2003 Sep; 25(9):732-4. PubMed ID: 12972810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary prophylaxis with voriconazole in a leukemic patient with pulmonary aspergillosis.
    Uriz J; de Andoin NG; Calvo C; Landa J; Onate E; Nogues A; Guerrero R
    Pediatr Infect Dis J; 2007 Oct; 26(10):971-2. PubMed ID: 17901816
    [No Abstract]   [Full Text] [Related]  

  • 35. [Two cases of pulmonary aspergillosis successfully treated with multidrug therapy].
    Anndo T
    Jpn J Antibiot; 2000 Feb; 53(2):84-90; dicussion 90. PubMed ID: 10896540
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful antifungal combination therapy with voriconazole and caspofungin.
    Schuster F; Moelter C; Schmid I; Graubner UB; Kammer B; Belohradsky BH; Führer M
    Pediatr Blood Cancer; 2005 Jun; 44(7):682-5. PubMed ID: 15700260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation.
    Auberger J; Lass-Flörl C; Clausen J; Bellmann R; Buzina W; Gastl G; Nachbaur D
    Diagn Microbiol Infect Dis; 2008 Nov; 62(3):336-9. PubMed ID: 18687556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disseminated invasive aspergillosis in a patient with acute leukaemia.
    Gottfredsson M; Steingrímsdóttir H
    Acta Biomed; 2006; 77 Suppl 2():10-3. PubMed ID: 16918060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of refractory chronic necrotizing pulmonary aspergillosis with micafungin.
    Ouchi H; Fujita M; Ikegame S; Inoshima I; Harada E; Nakanishi Y
    J Infect Chemother; 2007 Aug; 13(4):258-62. PubMed ID: 17721689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case reports. Invasive pulmonary aspergillosis in non-neutropenic patients treated with liposomal amphotericin B.
    Zhirong Y; Wanqing L; Weihua P
    Mycoses; 1999; 42(11-12):679-82. PubMed ID: 10680448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.